Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Burden of liver diseases in the world
2018 Standout
The importance of resistance to direct antiviral drugs in HCV infection in clinical practice
2015
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Antigenic analysis of the HIV-1 envelope trimer implies small differences between structural states 1 and 2
2022
Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
2015
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
AASLD guidelines for treatment of chronic hepatitis B
2015
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
2017
A Comprehensive Computational Analysis for the Binding Modes of Hepatitis C Virus NS5A Inhibitors: The Question of Symmetry
2016 StandoutNobel
Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis
2015
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Works of Peter Ackerman being referenced
Randomized, controlled trial of entecavir versus placebo in children with hepatitis B envelope antigen–positive chronic hepatitis B
2015
Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison
2016
Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection
2020
LP01 : Daclatasvir plus sofosbuvir for treatment of HCV genotypes 1-4 in HIV-HCV coinfection: The ALLY-2 study
2015